Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy
- PMID: 24042093
- PMCID: PMC3806909
- DOI: 10.1212/WNL.0b013e3182a84140
Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy
Abstract
Objective: To describe the hearing loss in facioscapulohumeral muscular dystrophy (FSHD) and examine the relationship to genotype.
Methods: Medical records of all individuals with FSHD seen at the University of Iowa neuromuscular clinic between July 2006 and July 2012 (n = 59) were reviewed. Eleven had significant hearing loss and no non-FSHD cause. All available audiology records for these individuals were analyzed. The relationship between the FSHD mutation (EcoRI/BlnI fragment size) and hearing loss was evaluated using a logistic regression analysis.
Results: In patients with hearing loss, recalled age at onset of facial weakness ranged from birth to 5 years and shoulder weakness was 3 to 15 years. The age at diagnosis of hearing loss ranged from birth to 7 years. Only 2 were identified by newborn hearing screen. Most audiograms demonstrated a bilateral, sloping, high-frequency sensorineural hearing loss. Of the 4 patients with more than 5 years of data, 3 had progression of hearing loss. Logistic regression showed statistically significant negative association between the presence of hearing loss and EcoRI/BlnI fragment size (p = 0.0207).
Conclusions: FSHD with a small EcoRI/BlnI fragment is associated with a bilateral, progressive, sloping, high-frequency hearing loss with onset in childhood. Patients with FSHD and small EcoRI/BlnI fragment sizes should have hearing screened, even if the child passed newborn hearing screening.
Figures


Comment in
-
Predicting hearing loss in facioscapulohumeral muscular dystrophy.Neurology. 2013 Oct 15;81(16):1370-1. doi: 10.1212/WNL.0b013e3182a841f7. Epub 2013 Sep 16. Neurology. 2013. PMID: 24042094 No abstract available.
References
-
- Tawil R, van der Maarel S, Padberg GW, van Engelen BG. 171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2010;20:471–475 - PubMed
-
- Voit T, Lamprecht A, Lenard HG, Goebel HH. Hearing loss in facioscapulohumeral dystrophy. Eur J Pediatr 1986;145:280–285 - PubMed
-
- Ganesh A, Kaliki S, Shields CL. Coats-like retinopathy in an infant with preclinical facioscapulohumeral dystrophy. J AAPOS 2012;16:204–206 - PubMed
-
- Felice KJ, Moore SA. Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle Nerve 2001;24:352–356 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources